News | October 10, 2024
India’s emergence as a hub for affordable medicines is commendable: Dr. Jitendra Singh
We now rank 3rd in pharmaceutical production by volume and 14th by value
We now rank 3rd in pharmaceutical production by volume and 14th by value
DKSH has entered into an exclusive partnership with R-Biomeds to bring the necessary medication to patients in Cambodia
US$ 800 million senior secured notes, the largest high yield debut USD bond issuance from India in the last 10 years
The Notes shall not be offered or sold in India
These clinical studies support the interchangeability of adalimumab-fkjp at low-concentration with high-concentration adalimumab and ustekinumab biosimilarity
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA
Target identification will commence on 17 September 2024, following the timeline provided in the campaign guidelines
Secretary Vaidya Rajesh Kotecha has urged senior officials to strive for the successful attainment of targets during the campaign
This case is an isolated case, similar to the earlier 30 cases reported in India from July 2022 onwards
Biocon Biologics earlier announced a settlement agreement in the United States for a Bmab 1200 launch no later than February 22, 2025
Subscribe To Our Newsletter & Stay Updated
